Brief: Oncolytics Biotech Inc Announces Positive Clinical Results Against Glioblastoma Multiforme
19/11/2020 14:15
Nov 19 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH INC - ANNOUNCES POSITIVE CLINICAL
RESULTS
AGAINST GLIOBLASTOMA MULTIFORME AT 2020 SOCIETY OF
NEURO-ONCOLOGY ANNUAL MEETING
Source text for Eikon: ID:nCNWWzBg8a
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer